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Background: Health care spending increases sharply at the end of
life. Little is known about variation of cost of end of life care
between regions and the drivers of such variation. We studied
small-area patterns of cost of care in the last year of life in
Switzerland.
Methods: We used mandatory health insurance claims data of in-
dividuals who died between 2008 and 2010 to derive cost of care.
We used multilevel regression models to estimate differences in
costs across 564 regions of place of residence, nested within 71
hospital service areas. We examined to what extent variation was
explained by characteristics of individuals and regions, including
measures of health care supply.
Results: The study population consisted of 113,277 individuals.
The mean cost of care during last year of life was 32.5k (thousand)
Swiss Francs per person (SD = 33.2k). Cost differed substantially
between regions after adjustment for patient age, sex, and cause of
death. Variance was reduced by 52%–95% when we added in-
dividual and regional characteristics, with a strong effect of lan-
guage region. Measures of supply of care did not show associations
with costs. Remaining between and within hospital service area
variations were most pronounced for older females and least for
younger individuals.
Conclusions: In Switzerland, small-area analysis revealed variation
of cost of care during the last year of life according to linguistic
regions and unexplained regional differences for older women.
Cultural factors contribute to the delivery and utilization of health
care during the last months of life and should be considered by
policy makers.
Key Words: end of life, health care cost, health insurance, regional
variation, palliative care, Switzerland
(Med Care 2017;55: 155–163)
Two factors characterize the Swiss health care system:high performance and high cost. Health care ex-
penditures (HCE) accounted for 11.4% of the gross domestic
product in 2012.1 Although advances in medicine contribute
to raising health care costs, HCE are unevenly distributed
across the life span and end of life (EOL) is often associated
with sharp increases in spending on health in an aging
poplation.2,3 A significant proportion of health care costs can
be attributed to the care of EOL patients.4
Differences in the use of health care between providers
and regions have been widely documented.5 However, doc-
umenting variation and identifying its causes is a nontrivial
exercise.6 Not all variation is bad or unwarranted and its
systematic, routine documentation at the local level is the
first step in addressing inefficiency of resource allocation and
overuse or underuse of services.5–8 Variation in intensity and
cost of EOL care (EOLC) can be of particular importance in
tracking regional differences in practice patterns.9,10
None of the previous Swiss EOLC studies11–16 has in-
vestigated small-area variation in costs despite the importance of
understanding local practice patterns, identifying unwarranted
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variation, and informing policy makers and clinicians.5,7,9,10,17
Previous work in the United Kingdom and the United States
either has not reported small-area variation in EOLC costs,18–20
or has used selected geographical locations19,21 or reported
variation at the level of hospital referral regions.9,10 Such re-
gions, however, similarly as cantons or language regions that are
often conveniently used in Swiss health services research, are
heterogenous in terms of population size and composition, do
not reflect areas where care is actually delivered and may
therefore be ill-suited for regional analyses.5,22–24 Furthermore,
analytical approaches used by previous studies have largely
failed to take into account the multilevel nature of data.25
We studied regional variation in cost of care during the
last 12 months of life in Switzerland. We constructed a na-
tionally representative dataset of cost of care and modelled
small-area variation in cost. We identified individual and
regional contextual factors and described how they shaped
variation in cost. We hypothesized the existence of sig-
nificant spatial variation in costs which is largely explained
by individual and regional factors, including measures of
health care supply.
METHODS
Study Design
This was a retrospective study based on routinely
collected, Swiss health insurance claims data.
Study Setting
Switzerland is a small European federal republic of 26
cantons, situated among the Alps, the Swiss Plateau, and the
Jura Mountains. The Swiss health care system is chiefly fi-
nanced by mandatory health insurance (MHI) and out-of-
pocket payments.1 The basic MHI package is compulsory for
each Swiss resident and covers all essential benefits deemed
medically and cost-appropriate that are related to illness and
pregnancy26 (Text 1, SDC, Supplemental Digital Content 1,
http://links.lww.com/MLR/B255).
Data Sources
We used anonymized MHI claims processed by 6 large
companies that insure approximately 40% of the population
(Table 1, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255). We included all individuals with MHI
who died during a 3-year period between January 1, 2008 and
December 31, 2010. Information on sex, age, date of birth and
death, and place of residence were available. The Swiss Federal
Statistical Office’s (SFSO) database of causes of death was
probabilistically linked to insurance records to derive in-
formation on cause of death, nationality, civil status, and religion
(Table 2, SDC, Supplemental Digital Content 1, http://link-
s.lww.com/MLR/B255). On the basis of SFSO data, we also
assessed representativeness of the study population. Character-
istics of communities, supply of health care together with pop-
ulation denominator were derived from available sources.
Analytical Regions
We used 705 MedStat regions—the smallest delivery
unit of health statistics—which SFSO constructs by ag-
gregating postcodes to assure population threshold of
approximately 10,000 residents. We further aggregated
these into 564 custom regions (hereinafter referred to as
regions) that best approximated SFSO’s boundaries of Swiss
administrative communities and allowed linkage to other
datasets. In total, 71 utilization-based hospital service areas
(HSA) were created from discharge data of all Swiss hos-
pitals in 2010 using methodology described elsewhere22
(Fig. 1, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255).
Study Population and Measures
We aggregated age into 5-year bands. Civil status was
categorized as single, married, widowed, or divorced; na-
tionality was recorded as Swiss or foreigner (including
missing values); and religion was recorded as Protestant,
Catholic, no affiliation, and other/unknown. Primary causes
of death, coded according to the 10th revision of the Inter-
national Statistical Classification of Diseases and Related
Health Problems, were aggregated into 16 categories: breast
cancer (women only, C50), prostate cancer (men, C61),
colorectal cancer (C18–C21), lung cancer (C33–C34), other
cancers (remaining C codes), heart failure27 (I50, I11.0,
I13.0, I13.2, J81), stroke16 (I60–I69), coronary heart dis-
ease16 (I20–I25), other cardiovascular diseases (remaining I
codes), chronic obstructive pulmonary disease28 (J40–J44,
J47), other respiratory diseases (remaining I codes), de-
mentia and Alzheimer’s29 (G30, G31.0, G31.82, G23.1, F00,
F01, F02, F03, F05.1), other mental and behavioral disorders
(remaining F codes), other diseases of the nervous system
(remaining G codes), external causes (V00–V99, W00–W99,
X00–X99, and Y00–Y99), and other.
Characteristics of regions of residence included level
of urbanization (urban, periurban, rural) and language
(German, French, Italian), both deriving from SFSO’s clas-
sification of communities; and quintiles of median area-
based socioeconomic position (Swiss-SEP) index30 (Fig. 1,
SDC, Supplemental Digital Content 1, http://links.lww.com/
MLR/B255). Ambulatory care supply was measured by
density of physicians per 10,000 inhabitants (regional level);
acute care, as number of utilized hospital beds per 10,000
inhabitants (HSA level), and nonacute care as number of
nursing home beds per 10,000 inhabitants 65 years and older
(HSA level; all supply measures in quintiles).
Analyses
We used all reimbursed claims from the last 12 months
of life to derive the overall cost of care for each person. We
calculated frequencies and described cost [mean (SD), me-
dian, 25th and 75th percentiles] across characteristics and
regions. We used individual-level data to fit multilevel re-
gression models; regions of place of residence were nested
within HSAs and the inverse hyperbolic sine31 transformed
cost was the main outcome. In sensitivity analyses we used
the last 3 months of life to derive costs.
Guided by previous Swiss EOLC studies,11,12,15,32 we
assessed interaction of sex and a binary age indicator
(19–65 y olds vs. those above 65 y) with remaining variables.
We considered 4 models of increasing complexity: model 1,
unadjusted; model 2, adjusted for age and cause of death;
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model 3, additionally adjusted for civil status, nationality,
religion, level of urbanization, Swiss-SEP, and 3 supply
measures; model 4, additionally adjusted for language
region.
To quantify the degree to which individual and re-
gional characteristics accounted for the observed regional
cost variation, we compared variance estimates of regional
cost variation across a sequence of models. We report the
percentage of reduction in variance achieved in more com-
plex models in comparison with the simplest model which
included neither individual nor region or HSA-specific
characteristics. Finally, based on the region-specific and
HSA-specific coefficients we calculated for each region the
ratio by which costs were higher or lower when compared
with the national mean (cost ratios). Data management and
analyses were performed in Stata version 14 (StataCorp LP,
College Station, TX).
Ethics
Ethical approval was obtained from the Ethics Com-
mittee of the Canton of Bern.
RESULTS
Study Population
The initial dataset consisted of 119,613 individuals.
We excluded 620 (0.5%) individuals below 19 years, 172
(0.1%) individuals who lived abroad, and 364 (0.3%) whose
address was missing. The remaining population was proba-
bilistically linked to 2008–2010 mortality data with 95.6%
success rate; 5180 unlinked individuals were similar to the
linked ones (Table 2, SDC, Supplemental Digital Content 1,
http://links.lww.com/MLR/B255) and were excluded. The
study population covered 61.3% of deaths in Switzerland
between 2008 and 2010. The sex, age, nationality, civil
status, level of urbanization, language region, Swiss-SEP
and, most importantly, cause of death distributions were
almost identical to overall mortality in that time period
(Table 3, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255).
The final study population consisted of 113,277 in-
dividuals (Table 1). As expected, women were older at the
time of death and main causes of death were cardiovascular
diseases and cancers. Younger individuals were more likely
to die of external causes than older persons. Study partici-
pants were mostly Swiss (92%), and either married (39%) or
widowed (40%) at the time of death. The distribution across
age and sex groups of religious affiliation, level of urban-
ization, and neighborhood SEP was similar.
Costs by Individual and Regional Characteristics
The mean cost of care during the last 12 months of life
was 32.5k (thousand; SD, 33.2k) Swiss Francs (CHF; 1
CHF = 0.90 Euro = 1.01 US Dollar, as of May 19, 2016)
(Table 4, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255). For both sexes, spending first tended
to increase with age, and then decrease among the oldest age
groups. Cancer deaths, especially colorectal, breast, and
prostate cancers among younger individuals, were associated
with the highest costs, followed by diseases of the nervous
system and respiratory diseases. Coronary heart disease,
external causes and, among younger individuals, mental and
behavioral diseases generated, on average, lower costs. Costs
tended to be higher among foreigners, married persons, and
those resident in Latin-speaking parts of Switzerland, and
areas of higher SEP. Costs were slightly lower in areas with a
higher density of nursing home beds and lower density of
hospital beds. Analyses of median cost showed similar trends
(Table 5, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255).
Geographical Variation in Costs
There was a 7-fold variation in mean crude costs be-
tween regions (Fig. 1). We found evidence of interactions of
sex and age with other variables (Table 6, SDC, Supple-
mental Digital Content 1, http://links.lww.com/MLR/B255).
We thus used separate models for younger (aged 19–65) and
older (66 and above) men and women. Sequentially includ-
ing more individual and regional characteristics in the
models gradually reduced cost variance at the HSA level
(Fig. 2, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255). Model 2, which included only age
and cause of death, reduced HSA-level variance by 46% for
younger men and 21% for women, with smaller reductions
achieved for older individuals (12% and 4%, respectively).
In addition, including further individual and regional char-
acteristics and health care supply measures resulted in a
small additional reduction of cost variability at the HSA
level (model 3). In contrast, also including language region
resulted in a substantial reduction of HSA-level cost varia-
bility (model 4): compared with model 1 without any in-
dividual or regional characteristics, HSA-level variance was
decreased by 95% for young males, 87% for females, 73%
for older males, and 51% for females.
After adjusting for age and cause of death (model 2),
the highest cost ratios were observed in the western (French-
speaking) parts of the country (regions around cities of
Lausanne and Geneva), in canton Ticino (Italian-speaking),
and in the large German-speaking cities (Basel, Bern,
Zurich) (Figs. 2, 3, left columns; Fig. 3, SDC, Supplemental
Digital Content 1, http://links.lww.com/MLR/B255 shows
unadjusted estimates). Higher costs among older individuals
were also present in parts of cantons Graubu¨nden and Valais.
In contrast, costs were lower in the valleys of the Alps and in
central and north-western Switzerland. These differences re-
mained in model 3 when adjusting for individual, regional,
and care supply covariates (Fig. 4, SDC, Supplemental Dig-
ital Content 1, http://links.lww.com/MLR/B255) but were
attenuated when also adjusting for language region (Figs. 2,
3, right columns). The largest spatial variation remained
among older women and the smallest among young in-
dividuals. Higher costs, mainly among older individuals,
were still present in and around large cities (Basel, Bern,
Zurich) and in parts of Canton Vaud. A belt of lower costs
stretched, in the north, from the cantons of Neuchatel to the
canton of Thurgau (with the exception of Basel), and in the
south along the Alps and the western part of Valais (partic-
ularly for older women). Importantly, regional level estimates
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of cost ratios varied within HSAs with neighboring regional
estimates of both high and low cost ratios in cantons Bern,
Geneva, and Zurich.
The estimates of the covariates changed little between
models 2 and 4 (Tables 7–10, SDC, Supplemental Digital
Content 1, http://links.lww.com/MLR/B255). The fully ad-
justed model 4 (Fig. 4; Table 10, SDC, Supplemental Digital
Content 1, http://links.lww.com/MLR/B255) showed wide
variation of cost across covariates. Adjusting for age, cause
of death had the strongest associations. We found moderate
effects of increased cost among individuals from French-
speaking and Italian-speaking parts of Switzerland. Health
care supply measures had little effect. Sensitivity analyses
based on the last 3 months showed similar results (Table 11,
Fig. 5, SDC, Supplemental Digital Content 1, http://links.
lww.com/MLR/B255).
DISCUSSION
Main Findings
Studying geographical variation in cost of care in the
last 12 months of life in Switzerland and assessing associa-
tions of costs with individual, regional, and health care
supply factors, we found cause of death and age of the
TABLE 1. Characteristics of the Study Population
n (%)
Characteristics Males (19–65) Males (65+) Females (19–65) Females (65+) Total
Age group (mean, SD) 53.9 (10.2) 81.4 (8.0) 54.4 (9.8) 85.3 (8.0) 79.0 (13.7)
Cause of death
Breast cancer — — 841 (13) 1747 (3) 2588 (2)
Prostate cancer 156 (1) 2297 (5) — — 2453 (2)
Lung cancer 1165 (10) 2591 (6) 699 (11) 1244 (2) 5699 (5)
Colorectal cancer 363 (3) 1322 (3) 269 (4) 1090 (2) 3044 (3)
Other cancer 2577 (23) 5712 (14) 1656 (25) 5752 (11) 15,697 (14)
Heart failure 81 (1) 1504 (4) 32 (0) 3234 (6) 4851 (4)
Coronary heart disease 1213 (11) 6782 (16) 254 (4) 7518 (14) 15,767 (14)
Stroke 229 (2) 2530 (6) 198 (3) 4298 (8) 7255 (6)
Other cardiovascular diseases 807 (7) 4621 (11) 335 (5) 7337 (14) 13,100 (12)
Chronic obstructive pulmonary disease 180 (2) 1852 (4) 121 (2) 1297 (2) 3450 (3)
Other respiratory diseases 153 (1) 1475 (4) 90 (1) 1866 (3) 3584 (3)
Dementia and Alzheimer’s 32 (0) 926 (2) 46 (1) 2039 (4) 3043 (3)
Other mental and behavioral disorders 293 (3) 2039 (5) 142 (2) 4547 (9) 7021 (6)
Other diseases of the nervous system 285 (3) 1043 (2) 220 (3) 1108 (2) 2656 (2)
External 1976 (18) 1675 (4) 696 (11) 1948 (4) 6295 (6)
Other 1769 (16) 5668 (13) 967 (15) 8370 (16) 16,774 (15)
Nationality
Swiss 9258 (82) 38,523 (92) 5715 (87) 50,704 (95) 104,200 (92)
Foreigner 2021 (18) 3514 (8) 851 (13) 2691 (5) 9077 (8)
Civil status
Single 3183 (28) 3444 (8) 1320 (20) 5792 (11) 13,739 (12)
Married 5899 (52) 25,029 (60) 3444 (52) 9751 (18) 44,123 (39)
Widowed 258 (2) 10,676 (25) 498 (8) 33,802 (63) 45,234 (40)
Divorced 1939 (17) 2888 (7) 1304 (20) 4050 (8) 10,181 (9)
Religion
Protestant 3958 (35) 20,741 (49) 2462 (37) 28,002 (52) 55,163 (49)
Catholic 4047 (36) 14,467 (34) 2345 (36) 18,327 (34) 39,186 (35)
No affiliation 1167 (10) 2178 (5) 632 (10) 1687 (3) 5664 (5)
Other/unknown 2107 (19) 4651 (11) 1127 (17) 5379 (10) 13,264 (12)
Urbanicity
Urban 3534 (31) 12,944 (31) 2095 (32) 18,757 (35) 37,330 (33)
Periurban 4926 (44) 18,327 (44 3017 (46) 22,126 (41) 48,396 (43)
Rural 2819 (25) 10,766 (26) 1454 (22) 12,512 (23) 27,551 (24)
Language region
German 7672 (68) 29,821 (71) 4588 (70) 37,994 (71) 80,075 (71)
French 3084 (27) 10,041 (24) 1722 (26) 12,420 (23) 27,267 (24)
Italian 523 (5) 2175 (5) 256 (4) 2981 (6) 5935 (5)
Swiss-SEP
1st (lowest) 835 (7) 3053 (7) 410 (6) 3477 (7) 7775 (7)
2nd 2455 (22) 9258 (22) 1307 (20) 11,155 (21) 24,175 (21)
3rd quintile 3223 (29) 11,345 (27) 1794 (27) 14,528 (27) 30,890 (27)
4th 3836 (34) 14,070 (33) 2380 (36) 19,150 (36) 39,436 (35)
5th (highest) 930 (8) 4311 (10) 675 (10) 5085 (10) 11,001 (10)
Total 11,279 (100) 42,037 (100) 6566 (100) 53,395 (100) 113,277 (100)
Mean (and SD) of age and frequencies and percentages across sex and age.
See text for the International Statistical Classification of Diseases-10 codes of the causes of death.
Swiss-SEP indicates Swiss neighbourhood index of socioeconomic position (see Panczak et al30 for details).
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decedent to be the most important determinants at the
individual level. We found that costs varied substantially
between regions and these differences were only partly ex-
plained by confounders. Measures of care supply showed no
associations with costs. When we included language region,
the spatial variation was reduced substantially, but especially
for elderly women, relevant differences between small re-
gions remained.
Strengths
Our study was based on a large and comprehensive
dataset of EOLC. Coverage and representativeness of the
data allowed us to analyze, for the first time, regional var-
iation in the cost of care during the last months of life.
Earlier Swiss studies have used language regions11,16 or
cantons12–14 to study regional variation in place of death and
intensity of EOLC. But as this study demonstrated, cantons
are heterogenous. Unlike other insurance-based studies from
Switzerland,11,13,15 we included cause of death information
FIGURE 1. Mean cost [in 1000s Swiss Francs (CHF)] of care in
the last 12 months of life among 113,277 individuals across
564 regions of place of residence, Switzerland 2008–2010.
HSA indicates hospital service area.
FIGURE 2. Spatial distribution of cost ratios adjusted for age and cause of death (model 2, left column) and fully adjusted (right
column) for males. Regional values derived from exponentiated random effects across 564 regions of place of residence, nested
within 71 hospital service areas (HSAs). Cost ratio represents the ratio by which regional costs are higher or lower when compared
with the national mean; for instance, coefficient of 1.2 indicates 1.2 times (or 20%) higher cost.
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and sociodemographic characteristics recorded on the death
certificate. By using MHI claims data, we were able to cover
the full range of care providers and include costs from am-
bulatory, inpatient, and nonacute settings. We evaluated in-
fluence of supply measures using utilization-based areas,
which are better suited for this purpose than administrative
units.7,22,23
Relation to Other Studies
Our findings of HCE during the last 12 months of life
are comparable with previous Swiss studies. Von Wyl et al15
estimated the median cost to be 30.3k CHF for individuals
aged 65 and above during the last 12 months of life, whereas
the cost of the last 6 months of life for the general population
determined by Reich et al11 was 17.7k CHF. These costs are
considerably higher than the mean annual HCE among the
general population in Switzerland, which is about 3.5k
CHF33; and 6.7k CHF per year for persons aged 65 and
above.32 Similar differences between the general and EOL
populations have been reported in the United States.34 Both
the Swiss and the American data reinforce the large eco-
nomic burden EOLC places on the health care system.
We found evidence for large geographic variation in
cost, yet were unable to completely explain its causes.
Similarly as in the United States, the cause of death, sex, and
age played an important role in determining costs on the
individual level,8,20 but these variables did not explain the
substantial spatial variation in costs, particularly among
older females. Nevertheless, the effect of language region
suggests that regional differences in volume and type of care
could be factors. We know the differences across Swiss
cantons in overall cost of care,35,36 overall number of hos-
pitalizations,5,37 and intensity of EOLC of cancer pa-
tients.12–14 Language region was also associated with
treatment intensity in ambulatory settings.38 These findings
overlap with ours: costs were higher in many regions of
French-speaking and Italian-speaking Switzerland. More
people died in the hospital than at home or in a nursing home
in French-speaking and Italian-speaking cantons, and as
hospital deaths tend to cost more this may be a partial ex-
planation.11,14,16 Doctors’ EOL decisions also vary across
FIGURE 3. Spatial distribution of cost ratios adjusted for age and cause of death (model 2, left column) and fully adjusted (right
column) for females. Regional values derived from exponentiated random effects across 564 regions of place of residence, nested
within 71 hospital service area (HSAs). Cost ratio represents the ratio by which regional costs are higher or lower when compared
with the national mean; for instance, coefficient of 1.2 indicates 1.2 times (or 20%) higher cost.
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cultural regions. Fischer and colleagues demonstrated, for
instance, that French-speaking physicians were more likely
to manage pain and symptoms aggressively, but were less
willing than their German-speaking colleagues to comply
with patients’ wishes of minimal or no treatment.39 We
found no association of costs with urbanization, but after
adjustment we found increased EOL costs in and around the
biggest cities. This has been reported earlier using Scottish
data in which it was suggested that differences in case-mix
and clinical practice increase cost in large urban centers.18 In
addition, in Switzerland, deaths at home, which are asso-
ciated with lower cost, are more common in rural areas,
which might explain part of this pattern.11
Health care supply was not associated with costs and
did not influence geographic variation. Density of physicians
was associated with EOLC intensity in the United States9,10
as were intensity and cost of general health care in
Switzerland in earlier studies.17,35,38 However, these studies
used data aggregated over large regions7 or lacked adjust-
ment for individual-level characteristics,8,20 which might
have influenced their results. Similarly, hospital bed density
was not associated with cost of care, which resembles pre-
vious results from Switzerland,40 but not from the United
States.9,10,41,42 Again, these studies used relatively large
spatial units that could have partly masked regional varia-
tion.7 It is also important to point out that the Swiss health
care system can be regarded as a fee-for-service system in
which suppliers may respond quickly to meet high demand,
thus making the effect of supply measures weaker than that
in studies from other countries. Alternatively, our results
may indicate that the mechanisms of supply-induced care do
not operate in EOLC in Switzerland.
Implications
Previous studies tracked variation in EOLC cost in
Switzerland across place of death11 and across time.15 This
study adds regional analyses, which can be used to involve
stakeholders and guide future EOLC studies in Switzerland.
Geographical variation in prevailing type of EOLC, the
coverage and strength of palliative care institutions, or
family and social support may be important determinants of
cost. High EOLC cost might not only indicate potential
FIGURE 4. Association of cost of care in the last 12 months of life across selected covariates of model 4 (fully adjusted) across sex
and age strata. Estimates additionally adjusted for age, civil status, nationality, religion, Swiss-SEP30 index, and level of urban-
ization. Exponentiated coefficients of regressing inverse hyperbolic sine31 transformed overall cost of care during the last 12
months of life representing cost ratios across analyzed variables. Cost ratio represents the ratio by which costs in specific category
are higher or lower when compared with the national mean; for instance, coefficient of 1.2 indicates 1.2 times (or 20%) higher
cost. All density of supply measures divided into quintiles of spatial units. CHD indicates coronary heart disease; CVD, car-
diovascular disease; COPD, chronic obstructive pulmonary disease; DNS, diseases of the nervous system; MBD, mental and
behavioral disorders; ref., reference category. See main text for International Statistical Classification of Diseases-10 codes of
the causes of death. See Tables 7–10, Supplemental Digital Content 1, http://links.lww.com/MLR/B255 for exact estimates of
coefficients across all covariates.
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waste of resources, but also potential overuse of costly
hospital-based services instead of appropriate palliative
care.21 Moreover, past EOLC spending in a region might be
used as an exposure in studies tracking variation in other
areas of health care.9
Supply of care did not seem to play a role; however,
we did identify significant variation that may indicate un-
deruse or overuse of services. But if regions that spend more
offer better quality of care and have higher patient sat-
isfaction, the rest of the country should follow suit. If future
research finds that this is not the case, then the areas high-
lighted by our findings should become the focus of regionally
tailored interventions. Finally, regional findings may point to
different patient preferences between regions. If meeting
these preferences, independent of medical needs, is consid-
ered a valid social goal,42 then substantial variation in cost of
care in the last months of life in Switzerland will persist.
The results of this study align with previous findings
and point to the importance of assessing utilization and
spending patterns at the local level.7 Large spatial units could
be heterogenous and too crude for planning policies. In ad-
dition, we found that cost of care was associated with lan-
guage region; countries with culturally diverse populations
and regions should consider these findings in future studies.
Finally, our methodology and findings could contribute to
understanding HCE in countries with similar health care
organization and demographics in which the extent of var-
iation has been documented, but the studies of its determi-
nants are still scarce.
Limitations
Studies based on health insurance claims contain limited
patient-level information. Quality or appropriateness of care
are also difficult to measure from administrative data. We
supplemented this data by linking to other sources, but im-
portant aspects of cost determinants may not be included; for
instance, we could not include measures of illness severity,43
patient and family preferences,42,44 functional status,3 presence
of relative nearby,45 or place of death.16 Second, overall cost is
only one possible outcome in analyses of EOLC,43,46,47 so our
ongoing analyses will aim at disaggregating costs across pro-
viders and exploring alternative measures of intensity of care.
Third, focusing on the last 12 months of life is an arbitrary
choice and can only be considered a proxy for EOLC, as it
might include unrelated costs.48 However, it is also one of the
most frequently used timeframes and facilitates comparability
with other studies. A retrospective design efficiently identifies
dying patients so we could construct large representative da-
tasets. Our study does not suffer from inaccurate prognosti-
cation of survival and incomplete enrolment of patients.
Langton et al47 describe 2 retrospective and prospective cancer
EOLC studies with comparable results.49,50 Our sensitivity
analyses indicated that shorter timeframe of 3 months provided
similar results. Fourth, relying only on MHI claims could cause
us to underestimate overall cost. Our estimates do not include
costs covered by supplementary insurance, claims paid directly
by patients, or costs not delivered to insurers.11,32 About 50%
of inpatient costs are subsidized by cantons and MHI pays only
about 18% of costs of nursing home stays (mainly for medical
treatments).15 Our sensitivity analyses showed that while
monetary cost understandably increases when we use cost
corrected for cantonal subsidies of hospital care and differ-
ences in tariffs for reimbursement of ambulatory care
(TARMED),2 the direction and strength of the associations
were unaffected (Table 12, Fig. 6, SDC, Supplemental Digital
Content 1, http://links.lww.com/MLR/B255).
CONCLUSIONS
MHI claims data show that in Switzerland HCE in the
last months of life vary strongly across regions, particularly
among older individuals. The effect of language region
might indicate that the organization of EOLC differs be-
tween cultural regions. However, supply of care does not
seem to play a major role. In light of the 2012 Swiss-wide
changes to a new inpatient reimbursement system, this study
provides a baseline for tracking the effects of these changes
on EOLC. Future Swiss and international studies should take
into account cultural factors of delivery and utilization of
health care.
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